Additional Effects of Segmental Breathing In Asthma

NCT04624425 | Completed DMC

• 1 other identifier: REC/00710 Asma Baig
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

To determine the effects of segmental breathing exercise and buteyko breathing exercises on chest expansion in individuals with asthma. To determine the effects of segmental breathing exercise and buteyko breathing exercises on pulmonary function (FEV1, FVC, FEV1/FVC) in individuals with asthma. To determine the effects of segmental breathing exercise and buteyko breathing exercises on Asthma Control Questionnaire in individuals with asthma.

Conditions

Asthma

Keywords

Asthma; Segmental Breathing

Outcome Measures

Primary Outcomes (7)

• Forced Expiratory Volume in 1 second (FEV1)

  Changes from the Baseline, the digital spirometer is used in clinical setting to analyze Forced Expiratory Volume in 1 second FEV1 in Liters

  2 weeks

• Forced vital Capacity (FVC)

  Changes From the Baseline, the digital spirometer is used in clinical setting to analyze Forced vital Capacity in Liters.

  2 weeks

• Modified Borg Scale of Perceived Exertion

  Changes from the Baseline, It is a subjective numeric scale ranging from 0 to 10, where 0 indicates "no dyspnea" and 10 indicates "unbearable dyspnea." A number is chosen by the patient in order to decide the best score that matches his level of dyspnea during physical activity.

  2 weeks

• Chest Expansion measurement at Axillary level

  A measuring tape with centimeters scale will be used for measuring the expansion at Axillary level. Changes from the baseline will be measured.

  2 weeks

• Chest Expansion measurement at Spinal cord T4 level

  A measuring tape with centimeters scale will be used for measuring the expansion at at Spinal cord T4 level. Changes from the baseline will be measured.

  2 weeks

• Chest Expansion measurement at xiphoid process

  A measuring tape with centimeters scale will be used for measuring the expansion at xiphoid process level. Changes from the baseline will be measured.

  2 weeks

• Asthma Control Questionnaire

  Measurement of the adequateness of asthma control and modifications in asthma control which may occurs immediately or as a consequence of treatment. It is a 7-point scale (0=no impairment, 6= maximum impairment for symptoms and rescue use; and 7 categories for FEV1%). Scores range between 0 (totally controlled) and 6 (severely uncontrolled) .The 7-items Asthma Control Questionnaire (ACQ) is valid to measure the goals of asthma management as defined by international guideline. Changes from the baseline will be measured.

  2 weeks

Study Arms (2)

Segmental breathing exercises

EXPERIMENTAL

Segmental breathing exercises, Treatment session will be last for 10-15 minutes. For 2 Weeks

Other: Segmental breathing exercises

Buteyko breathing exercises

ACTIVE COMPARATOR

Buteyko breathing exercises, Treatment session will be last for 10-15 minutes. For 2 Weeks

Other: Buteyko breathing exercises

Interventions

Segmental breathing exercises OTHER

Segmental breathing exercises along with the Conventional Treatment of buteyko breathing exercises for two weeks of duration. Segmental breathing exercises include 18-20 breaths in one session (6 breaths/min) with rest interval after every 6 breaths.

Segmental breathing exercises

Buteyko breathing exercises OTHER

Buteyko exercises for two weeks of duration. Treatment session will be last for 10-15minutes.

Buteyko breathing exercises

Eligibility Criteria

• Age: 20 Years - 45 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Individuals with clinical diagnosis of asthma.

You may not qualify if:

• Participants with unbearable chest pain, chylothorax, hemothorax, pneumothorax.
• Participants with pleura disorder and chest trauma \& rib fracture.

Sponsors & Collaborators

• Riphah International University: lead

Study Sites (1)

Nusrat Abdul Rauf Centre for Enablement (NACE)

Faisalābad, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Iqbal Tariq, MSPT-CPPT

  Riphah International University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 5, 2020
• First Posted: November 10, 2020
• Study Start: September 9, 2020
• Primary Completion: December 20, 2020
• Study Completion: December 20, 2020
• Last Updated: January 13, 2021

Record last verified: 2021-01

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)